8-K filing — SANUWAVE Health, Inc. (SNWV)
Filed: 2026-09-25 AccNo: 0001628280-26-063594 Size: 133 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Stocks · News reference
SANUWAVE Health Q2 EPS $(0.08) Down From $(0.04) YoY, Sales $9.739M Down From $10.054M YoY
SANUWAVE Health (NASDAQ:SNWV) reported quarterly losses of $(0.08) per share. This is a 100 percent decrease over losses of $(0.04) per share from the same period last year. The company reported $9.739 million in sales
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Sanuwave Announces Q2 FY2026 Financial Results
Sanuwave Health (NASDAQ: SNWV) reported Q2 2026 revenues of $9.7 million, down 3% year-over-year, with gross margins declining to 76.2% from 78.1%. The company posted an operating loss of $0.3 million versus operating income of $1.4 million in Q2 2025. While Ultramist applicator revenue grew 13%, system sales declined significantly due to CMS reimbursement pressures and a secondary market for used equipment. The company has withdrawn its 2026 guidance pending clarity on Medicare reimbursement developments.
What's Going on With SANUWAVE Health Stock on Friday?
NASDAQ:SNWV shares are trading down 0.5% in premarket as SANUWAVE Health beats Q2 revenue expectations, but faces financial constraints and competition.